0001104659-24-025684.txt : 20240220 0001104659-24-025684.hdr.sgml : 20240220 20240220195218 ACCESSION NUMBER: 0001104659-24-025684 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240220 DATE AS OF CHANGE: 20240220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCPEAK MERRILL A CENTRAL INDEX KEY: 0001210317 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36860 FILM NUMBER: 24655933 MAIL ADDRESS: STREET 1: PO BOX 500 (M/S 55-985) STREET 2: 14200 SW KARL BRAUN DRIVE CITY: BEAVERTON STATE: OR ZIP: 97077-0001 FORMER NAME: FORMER CONFORMED NAME: MCPEAK MERRILL A/ DATE OF NAME CHANGE: 20021214 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IOVANCE BIOTHERAPEUTICS, INC. CENTRAL INDEX KEY: 0001425205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 753254381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6502607120 MAIL ADDRESS: STREET 1: 825 INDUSTRIAL ROAD STREET 2: 4TH FLOOR CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: Lion Biotechnologies, Inc. DATE OF NAME CHANGE: 20131015 FORMER COMPANY: FORMER CONFORMED NAME: Genesis Biopharma, Inc DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: FREIGHT MANAGEMENT CORP DATE OF NAME CHANGE: 20080128 4 1 tm246751-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-20 0 0001425205 IOVANCE BIOTHERAPEUTICS, INC. IOVA 0001210317 MCPEAK MERRILL A C/O IOVANCE BIOTHERAPEUTICS, INC. 825 INDUSTRIAL ROAD, 4TH FLOOR SAN CARLOS CA 94070 1 0 0 0 0 Common Stock 2024-02-20 4 P 0 250000 9.15 A 320150 D Common Stock 248633 I By Trust These shares are held by a family trust for which the reporting person is a trustee. Such shares purchased pursuant to Issuer's underwritten offering, which priced on 02/20/2024. Such number does not include 103,159 deferred restricted stock units, which are vested but not yet issued. Consists of 30,150 shares held in Keogh retirement account plus 40,000 shares as a result of exercised stock options plus 250,000 shares acquired in this offering. /s/ Merrill A. McPeak 2024-02-20